Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1920375 | Parkinsonism & Related Disorders | 2016 | 6 Pages |
Abstract
In depressed PD patients treated with venlafaxine or paroxetine, affective symptoms improved first, followed by somatic symptoms and cognitive symptoms. These findings could guide patient counselling and increase patient compliance by informing about the expected treatment responses. The substantial placebo effect underlines the importance of a sufficiently long study period in future studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
M.P.G. Broen, A.F.G. Leentjens, S. Köhler, M.L. Kuijf, W.M. McDonald, I.H. Richard,